XML 250 R167.htm IDEA: XBRL DOCUMENT v3.20.4
Equity-based participation plans for associates (Details 5) - Non-vested shares granted [member]
$ / shares in Units, Pure in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2020
USD ($)
$ / shares
Dec. 31, 2019
USD ($)
$ / shares
Schedule of unvested restricted stock units [roll forward]    
Number of shares at beginning of period 25.8 25.7
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement at beginning of period | $ / shares $ 71.1 $ 77.1
Fair value at grante date at beginning of period | $ $ 1,835 $ 1,981
Vested, number of shares (13.8) (13.3)
Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement | $ / shares $ 74.2 $ 80.3
Vested, fair value at grante date | $ $ (1,024) $ (1,068)
Forfeited, number of shares (2.0) (4.3)
Weighted average exercise price of other equity instruments forfeited in share-based payment arrangement | $ / shares $ 75.3 $ 76.3
Forfeited, fair value at grante date | $ $ (151) $ (328)
Number of shares at end of period 24.8 25.8
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement at end of period | $ / shares $ 78.9 $ 71.1
Fair value at grante date at end of period | $ $ 1,957 $ 1,835
Annual incentive    
Schedule of unvested restricted stock units [roll forward]    
Granted, number of shares 1.1 1.1
Weighted average exercise price of other equity instruments granted in share-based payment arrangement | $ / shares $ 93.7 $ 78.4
Granted, fair value at grante date | $ $ 103 $ 86
Share savings plans    
Schedule of unvested restricted stock units [roll forward]    
Granted, number of shares 4.2 4.2
Weighted average exercise price of other equity instruments granted in share-based payment arrangement | $ / shares $ 95.0 $ 83.0
Granted, fair value at grante date | $ $ 399 $ 349
Select North America    
Schedule of unvested restricted stock units [roll forward]    
Granted, number of shares 3.3 5.3
Weighted average exercise price of other equity instruments granted in share-based payment arrangement | $ / shares $ 86.7 $ 64.0
Granted, fair value at grante date | $ $ 286 $ 339
Select outside North America    
Schedule of unvested restricted stock units [roll forward]    
Granted, number of shares 2.0 2.6
Weighted average exercise price of other equity instruments granted in share-based payment arrangement | $ / shares $ 89.4 $ 67.4
Granted, fair value at grante date | $ $ 179 $ 175
Long-Term Performance Plan    
Schedule of unvested restricted stock units [roll forward]    
Granted, number of shares 2.5 2.5
Weighted average exercise price of other equity instruments granted in share-based payment arrangement | $ / shares $ 85.1 $ 68.9
Granted, fair value at grante date | $ $ 213 $ 172
Long-Term Relative Performance Plan    
Schedule of unvested restricted stock units [roll forward]    
Granted, number of shares 0.2 0.1
Weighted average exercise price of other equity instruments granted in share-based payment arrangement | $ / shares $ 0.0 $ 0.0
Granted, fair value at grante date | $ $ 0 $ 0
Other share awards    
Schedule of unvested restricted stock units [roll forward]    
Granted, number of shares 1.5 1.9
Weighted average exercise price of other equity instruments granted in share-based payment arrangement | $ / shares $ 78.0 $ 67.7
Granted, fair value at grante date | $ $ 117 $ 129